![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BGI Genomics’ COVID-19 Test Gets Canadian Authorization
BGI Genomics’ COVID-19 Test Gets Canadian Authorization
![Canada flag](https://www.fdanews.com/ext/resources/test/Drug-Images4/Canada_Flag.gif?t=1627934481&width=430)
BGI Genomics received authorization from Health Canada to distribute its real-time fluorescent COVID-19 polymerase chain reaction test in Canada.
The diagnostic tests respiratory samples for coronavirus RNA and produces results within three hours.
The company said it can manufacture 2 million tests per day and is handling orders from more than 80 countries.
Upcoming Events
-
21Oct